Akari Therapeutics Presents Promising Immuno-Oncology Data for its Novel Splicing-Targeted ADC Payload Driving Immune Activation, Both as Single Agent and in Com…

Data presented at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting The spliceosome targeting payload, PH1, ...
TipRanks on MSN

Akari Therapeutics announces presentation of mechanism of action data for PH1

Akari Therapeutics (AKTX) announced the presentation of immune mechanism-of-action data for its novel ADC payload, PH1. The Company will host a ...
India West

Ten Indian American Scientists Awarded for Contributions in Cancer Research

NEW ORLEANS, LA – Ten Indian American scientists were honored for their outstanding contributions in cancer research by the Society of American Asian Scientists in Cancer Research (SAASCR) on April 10 ...

Akari Therapeutics Presents Promising Immuno-Oncology Data for its Novel Splicing-Targeted ADC Payload Driving Immune Activation, Both as Single Agent and in Com…

Data presented at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting The spliceosome targeting payload, PH1, ...